Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Titan Pharma (TTNP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,136
  • Shares Outstanding, K 12,998
  • Annual Sales, $ 220 K
  • Annual Income, $ -14,310 K
  • 60-Month Beta 0.69
  • Price/Sales 1.15
  • Price/Cash Flow N/A
  • Price/Book 2.12

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.31 +34.35%
on 02/20/19
2.45 -28.16%
on 02/25/19
+0.23 (+15.03%)
since 02/15/19
3-Month
1.18 +49.15%
on 01/30/19
2.45 -28.16%
on 02/25/19
+0.02 (+1.15%)
since 12/18/18
52-Week
1.03 +70.54%
on 10/03/18
8.40 -79.05%
on 03/22/18
-4.36 (-71.24%)
since 03/16/18

Most Recent Stories

More News
Thinking about buying stock in Advanced Micro Devices, General Electric, China Internet Nationwide, Spark Therapeutics or Titan Pharmaceuticals?

InvestorsObserver issues critical PriceWatch Alerts for AMD, CIFS, GE, ONCE, and TTNP.

ONCE : 113.96 (+0.33%)
TTNP : 1.76 (-1.12%)
AMD : 23.25 (-0.17%)
CIFS : 3.01 (+9.06%)
GE : 10.20 (+2.41%)
Titan Pharmaceuticals Partners With AllianceRx Walgreens Prime Specialty Pharmacy To Expand Patient Access To Probuphine®

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) today announced the execution of a specialty pharmacy distribution and services agreement with AllianceRx Walgreens Prime that will expand patient access to treatment...

TTNP : 1.76 (-1.12%)
Titan Pharmaceuticals Selects Life Sciences Business Intelligence CRM Innovator, TikaMobile, to Empower its Sales and MSL Teams

TikaMobile, a premier cloud-based business intelligence CRM provider for the life sciences industry, today announced that Titan Pharmaceuticals, Inc. has selected Tika's BI/CRM platform to deliver real-time,...

TTNP : 1.76 (-1.12%)
Cancer Drug Development Shows That Government and Private Sector can Work Together

Considering that yesterday, February 4, was World Cancer Day, it is encouraging that the private sector and the U.S. government are mutually trying to solve a serious problem and are in fact, working closely...

EOLS : 23.85 (-3.95%)
AGEN : 2.88 (+0.35%)
TTNP : 1.76 (-1.12%)
QGEN : 39.69 (-0.38%)
MBRX : 1.25 (-1.57%)
4 Healthcare Stocks Looking To Start February Off Strong

CORAL GABLES, FL / ACCESSWIRE / February 1, 2019 / The market's success is largely dependent on the fact that, as the global population increases, more people will fall prey to illnesses and ailments,...

TTNP : 1.76 (-1.12%)
PHGI.CN : 0.760 (+1.33%)
ALRN : 2.08 (+9.47%)
PHGRF : 0.5520 (-3.93%)
ENOB : 6.82 (-2.43%)
Pipeline Update, Review and Progress Titan Pharmaceuticals, Inc.

NEW YORK, NY / ACCESSWIRE / February 1, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive...

TTNP : 1.76 (-1.12%)
Titan Pharmaceuticals Reports Positive Initial Results Of Probuphine® Relaunch

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), today provided an update on the U.S. commercial relaunch of Probuphine (buprenorphine) implant, its unique six-month treatment for Opioid Use Disorder (OUD)....

TTNP : 1.76 (-1.12%)
Titan Pharmaceuticals Announces Reverse Stock Split

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a commercial stage company developing proprietary therapeutics using its ProNeura(TM) long-term continuous drug delivery technology, announced today that it...

TTNP : 1.76 (-1.12%)
Biotech Stocks Beating the Market

HENDERSON, NV / ACCESSWIRE / December 10, 2018 / Here are several biotech plays to pay close attention to in the coming sessions.

CRON : 21.69 (+3.29%)
TTNP : 1.76 (-1.12%)
CLVS : 27.48 (+0.15%)
MNKD : 2.15 (-2.27%)
Alternatives to Watch

HENDERSON, NV / ACCESSWIRE / December 10, 2018 / Below are several companies positioning themselves to be a viable opioid alternative.

CARA : 19.06 (+3.76%)
COLL : 17.59 (+3.59%)
TTNP : 1.76 (-1.12%)
INSY : 4.39 (+6.04%)
ENDV : 0.0186 (-11.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade TTNP with:

Business Summary

Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical...

See More

Key Turning Points

2nd Resistance Point 1.86
1st Resistance Point 1.81
Last Price 1.76
1st Support Level 1.73
2nd Support Level 1.70

See More

52-Week High 8.40
Fibonacci 61.8% 5.59
Fibonacci 50% 4.72
Fibonacci 38.2% 3.85
Last Price 1.76
52-Week Low 1.03

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar